Should Participants in Clinical Trials Be Able to Withdraw from Passive Follow‐Up?-Reference-Cited by-同舟云学术

Should Participants in Clinical Trials Be Able to Withdraw from Passive Follow‐Up?

Published:2021-01 Issue:1 Volume:43 Page:32-36
ISSN:2578-2355
Container-title:Ethics & Human Research
language:en
Short-container-title:Ethics & Human Research

Author:

Capell Warren H.¹,Wynia Matthew K.²,Hurley Elisa A.³,Bonaca Marc P.⁴

Affiliation:

1. Associate professor of medicine at CPC Clinical Research at the University of Colorado Anschutz Medical Campus in the Department of Medicine at the University of Colorado Center for Bioethics and Humanities

2. Professor of medicine and public health at the University of Colorado Anschutz Medical Campus in the Department of Medicine at the University of Colorado Center for Bioethics and Humanities

3. Executive director at Public Responsibility in Medicine & Research

4. Professor of medicine at CPC Clinical Research at the University of Colorado Anschutz Medical Campus in the Department of Medicine

Publisher

Wiley

Subject

Health(social science)

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/eahr.500077

Reference13 articles.

1. Loss to Follow-Up in Cohort Studies: How Much Is Too Much?;Kristman V.;European Journal of Epidemiology,2004

2. Potential Impact on Estimated Treatment Effects of Information Lost to Follow-Up in Randomised Controlled Trials (LOST-IT): Systematic Review;Akl E. A.;British Medical Journal,2012

3. Completeness of Follow-Up Determines Validity of Study Findings: Results of a Prospective Repeated Measures Cohort Study

4. The ATLAS ACS 2-TIMI Trial and the Burden of Missing Data: (Anti-Xa Therapy to Lower Cardiovascular Events in Addition to Standard Therapy in Subjects with Acute Coronary Syndrome ACS 2-Thrombolysis in Myocardial Infarction 51);Krantz M. J.;Journal of the American College of Cardiology,2013

5. The Prevention and Treatment of Missing Data in Clinical Trials;Little R. J.;New England Journal of Medicine,2012